Reviewing peripartum cardiomyopathy: current state of knowledge

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Gouley BA, McMillan T, Bellet S: Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am. J. Med. Sci.194,185–199 (1937).
  Google Scholar
• 2  Pearson GD, Veille JC, Rahimtoola S et al.: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA283,1183–1188 (2000).▪▪ Fundamental review whereby the generally accepted criteria for peripartum cardiomyopathy (PPCM) are defined.
  Medline CASGoogle Scholar
• 3  Sliwa K, Fett J, Elkayam U: Peripartum cardiomyopathy. Lancet368,687–693 (2006).▪ Provides a general overview on PPCM.
  MedlineGoogle Scholar
• 4  Ntusi NB, Mayosi BM: Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int. J. Cardiol.131,168–179 (2009).▪▪ Extended overview of etiology and risk factors with detailed discussion of the items.
  MedlineGoogle Scholar
• 5  Hilfiker-Kleiner D, Meyer GP, Schieffer E et al.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J. Am. Coll. Cardiol.50,2354–2355 (2007).
  MedlineGoogle Scholar
• 6  Fett JD, Christie LG, Carraway RD, Ansari AA, Sundstrom JB, Murphy JG: Unrecognized peripartum cardiomyopathy in Haitian women. Int. J. Gynaecol. Obstet.90,161–166 (2005).
  Medline CASGoogle Scholar
• 7  Fett JD, Christie LG, Carraway RD, Murphy JG: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin. Proc.80,1602–1606 (2005).
  MedlineGoogle Scholar
• 8  Hilfiker-Kleiner D, Sliwa K, Drexler H: Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc. Med.18(5),173–179 (2008).▪▪ Discusses PPCM with special emphasis on new therapy options.
  Medline CASGoogle Scholar
• 9  Mayosi BM: Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart93,1176–1183 (2007).
  MedlineGoogle Scholar
• 10  Brar SS, Khan SS, Sandhu GK et al.: Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am. J. Cardiol.100,302–304 (2007).
  MedlineGoogle Scholar
• 11  Elkayam U, Akhter MW, Singh H et al.: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation111,2050–2055 (2005).▪▪ Detailed information for clinicians regarding the presentation of PPCM.
  MedlineGoogle Scholar
• 12  Reimhold SC, Rutherford JD: Peripartum cardiomyopathy. N. Engl. J. Med.344(21),1629–1630 (2001).
  MedlineGoogle Scholar
• 13  Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J. Am. Coll. Cardiol.35,701–705 (2000).
  Medline CASGoogle Scholar
• 14  Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P: The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur. J. Heart Fail.4,305–309 (2002).
  Medline CASGoogle Scholar
• 15  Hilfiker-Kleiner D, Kaminski K, Podewski E et al.: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell128,589–600 (2007).▪ Detailed work on the mechanism of how prolactin is involved in PPCM.
  Medline CASGoogle Scholar
• 16  Hilfiker-Kleiner D, Schieffer E, Meyer GP, Podewski E, Drexler H: Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists and cardiologists. Deutsches Ärzteblatt Int.105,751–756 (2008).
  MedlineGoogle Scholar
• 17  Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM: Peripartum cardiomyopathy: a comprehensive review. Int. J. Cardiol.118,295–303 (2007).
  MedlineGoogle Scholar
• 18  Ibebuogu UN, Thornton JW, Reed GL: An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena. Thromb. J.5,18 (2007).
  MedlineGoogle Scholar
• 19  Stepan H, Walther T, Pfeiffer D: Peripartum cardiomyopathy – the(un)known obstetricalcardiologic emergency situation. Z. Kardiol.92,811–816 (2003).
  Medline CASGoogle Scholar
• 20  Mouquet F, Lions C, de Groote P et al.: Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur. Radiol.18,2765–2769 (2008).
  MedlineGoogle Scholar
• 21  Kawano H, Tsuneto A, Koide Y et al.: Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Intern. Med.47,97–102 (2008).
  MedlineGoogle Scholar
• 22  Baughman KL: Management of a case of peripartum cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med.3,514–518; quiz 518 (2006).
  MedlineGoogle Scholar
• 23  Habedank D, Kuhnle Y, Elgeti T, Dudenhausen JW, Haverkamp W, Dietz R: Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur. J. Heart Fail.10,1149–1151 (2008).
  Medline CASGoogle Scholar
• 24  Nishi I, Ishimitsu T, Ishizu T et al.: Peripartum cardiomyopathy and biventricular thrombi. Circ. J.66,863–865 (2002).
  MedlineGoogle Scholar
• 25  Forster O, Hilfiker-Kleiner D, Ansari AA et al.: Reversal of IFN-γ, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur. J. Heart Fail.10,861–868 (2008).▪ Correlation of serum levels with the risk of PPCM.
  Medline CASGoogle Scholar
• 26  Fett JD, Dowell DL, Carraway RD, Sundstrom JB, Ansari AA: One hundred cases of peripartum cardiomyopathy … and counting: what is going on? Int. J. Cardiol.97,571–573 (2004).
  Medline CASGoogle Scholar
• 27  Sliwa K, Forster O, Libhaber E et al.: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur. Heart J.27,441–446 (2006).▪ One of the rare prospective studies regarding PPCM. The outcome is correlated with various serum markers.
  Medline CASGoogle Scholar
• 28  Bhakta P, Biswas BK, Banerjee B: Peripartum cardiomyopathy: review of the literature. Yonsei Med. J.48,731–747 (2007).
  Medline CASGoogle Scholar
• 29  Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM: Peripartum heart failure associated with prolonged tocolytic therapy. Am. J. Obstet. Gynecol.168,493–495 (1993).
  Medline CASGoogle Scholar
• 30  Mielniczuk LM, Williams K, Davis DR et al.: Frequency of peripartum cardiomyopathy. Am. J. Cardiol.97,1765–1768 (2006).
  MedlineGoogle Scholar
• 31  Munjuluri N, Lipman M, Valentine A, Hardiman P, Maclean AB: Postpartum eclampsia of late onset. BMJ331,1070–1071 (2005).
  MedlineGoogle Scholar
• 32  Roberts JM, Gammill HS: Preeclampsia: recent insights. Hypertension46,1243–1249 (2005).
  Medline CASGoogle Scholar
• 33  Castelao JE, Gago-Dominguez M: Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med. Hypotheses71,39–44 (2008).
  Medline CASGoogle Scholar
• 34  Mattar F, Sibai BM: Eclampsia. VIII. Risk factors for maternal morbidity. Am. J. Obstet. Gynecol.182,307–312 (2000).
  Medline CASGoogle Scholar
• 35  Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM: Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am. J. Obstet. Gynecol.174,975–982 (1996).
  Medline CASGoogle Scholar
• 36  Sacks GP, Studena K, Sargent K, Redman CW: Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol.179,80–86 (1998).
  Medline CASGoogle Scholar
• 37  Sibai BM, el-Nazer A, Gonzalez-Ruiz A: Severe preeclampsia – eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am. J. Obstet. Gynecol.155,1011–1016 (1986).
  Medline CASGoogle Scholar
• 38  Mehta NJ, Mehta RN, Khan IA: Peripartum cardiomyopathy: clinical and therapeutic aspects. Angiology52,759–762 (2001).
  Medline CASGoogle Scholar
• 39  Fok WY, Chan LY, Wong JT, Yu CM, Lau TK: Left ventricular diastolic function during normal pregnancy: assessment by spectral tissue Doppler imaging. Ultrasound Obstet. Gynecol.28,789–793 (2006).
  Medline CASGoogle Scholar
• 40  Homans DC: Peripartum cardiomyopathy. N. Engl. J. Med.312,1432–1437 (1985).
  Medline CASGoogle Scholar
• 41  Lampert MB, Lang RM: Peripartum cardiomyopathy. Am. Heart J.130,860–870 (1995).
  Medline CASGoogle Scholar
• 42  Mabie WC, DiSessa TG, Crocker LG, Sibai BM, Arheart KL: A longitudinal study of cardiac output in normal human pregnancy. Am. J. Obstet. Gynecol.170,849–856 (1994).
  Medline CASGoogle Scholar
• 43  Mesa A, Falcone M, Hernandez A, Stainback RF, Wilansky S: Long-term prognosis in women with normal dobutamine stress echocardiography. Am. J. Cardiol.83,1127–1129, A9 (1999).
  Medline CASGoogle Scholar
• 44  Veille JC, Hosenpud JD, Morton MJ: Cardiac size and function in pregnancy-induced hypertension. Am. J. Obstet. Gynecol.150,443–449 (1984).
  Medline CASGoogle Scholar
• 45  Gonzalez AM, Osorio JC, Manlhiot C, Gruber D, Homma S, Mital S: Hypertrophy signaling during peripartum cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol.293,H3008–H3013 (2007).
  Medline CASGoogle Scholar
• 46  Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM: Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am. Heart J.133,53–59 (1997).
  Medline CASGoogle Scholar
• 47  Robson SC, Hunter S, Boys RJ, Dunlop W: Hemodynamic changes during twin pregnancy. A Doppler and M-mode echocardiographic study. Am. J. Obstet. Gynecol.161,1273–1278 (1989).
  Medline CASGoogle Scholar
• 48  Simmons LA, Gillin AG, Jeremy RW: Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am. J. Physiol. Heart Circ. Physiol.283,H1627–H1633 (2002).
  Medline CASGoogle Scholar
• 49  Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am. J. Obstet. Gynecol.176,189–195 (1997).
  Medline CASGoogle Scholar
• 50  Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R: High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am. J. Obstet. Gynecol.193,363–365 (2005).
  MedlineGoogle Scholar
• 51  Cenac A, Djibo A, Djangnikpo L: Peripartum dilated cardiomyopathy. A model of multifactor disease? Rev. Med. Intern.14,1033 (1993).
  Medline CASGoogle Scholar
• 52  Cenac A, Gaultier Y, Devillechabrolle A, Moulias R: Enterovirus infection in peripartum cardiomyopathy. Lancet2,968–969 (1988).
  Medline CASGoogle Scholar
• 53  Fett JD: Viral infection as a possible trigger for the development of peripartum cardiomyopathy. Int. J. Gynaecol. Obstet.97,149–150 (2007).
  Medline CASGoogle Scholar
• 54  Cenac A, Simonoff M, Moretto P, Djibo A: A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. Int. J. Cardiol.36,57–59 (1992).
  Medline CASGoogle Scholar
• 55  Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL: Peripartum myocarditis and cardiomyopathy. Circulation81,922–928 (1990).
  Medline CASGoogle Scholar
• 56  O’Connell JB, Costanzo-Nordin MR, Subramanian R et al.: Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J. Am. Coll. Cardiol.8,52–56 (1986).
  MedlineGoogle Scholar
• 57  Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME: Incidence of myocarditis in peripartum cardiomyopathy. Am. J. Cardiol.74,474–477 (1994).
  Medline CASGoogle Scholar
• 58  Felker GM, Jaeger CJ, Klodas E et al.: Myocarditis and long-term survival in peripartum cardiomyopathy. Am. Heart J.140,785–791 (2000).
  Medline CASGoogle Scholar
• 59  Yokoyama T, Kanda T, Suzuki T, Murata K: Enhancement of myocardial damage and alteration of lymphocyte subsets in murine model of postpartum myocarditis. Am. J. Cardiovasc. Pathol.4,343–351 (1993).
  Medline CASGoogle Scholar
• 60  Bultmann BD, Klingel K, Sotlar K et al.: Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum. Pathol.34,92–95 (2003).
  MedlineGoogle Scholar
• 61  Koch WC: Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr. Opin. Infect. Dis.14,343–356 (2001).
  Medline CASGoogle Scholar
• 62  D’Cruz IA, Fonseca JM, Parmar VT: Medical causes of maternal mortality. J. Assoc. Physicians India16,417–424 (1968).
  MedlineGoogle Scholar
• 63  Kovithavongs T, Dossetor JB: Suppressor cells in human pregnancy. Transplant Proc.10,911–913 (1978).
  Medline CASGoogle Scholar
• 64  Thong YH, Steele RW, Vincent MM, Hensen SA, Bellanti JA: Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. N. Engl. J. Med.289,604–606 (1973).
  Medline CASGoogle Scholar
• 65  Vinatier D, Monnier JC: Evaluation of the defense mechanisms of the body during pregnancy. Clinical and experimental aspects. J. Gynecol. Obstet. Biol. Reprod. (Paris)17,579–584 (1988).
  Medline CASGoogle Scholar
• 66  Drexler H, Kurz S, Jeserich M, Munzel T, Hornig B: Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am. J. Cardiol.76,13E–18E (1995).
  Medline CASGoogle Scholar
• 67  Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K: C-reactive protein co-expresses with tumor necrosis factor-α in the myocardium in human dilated cardiomyopathy. Eur. J. Heart Fail.7,748–754 (2005).
  Medline CASGoogle Scholar
• 68  Vuolteenaho O, Ala-Kopsala M, Ruskoaho H: BNP as a biomarker in heart disease. Adv. Clin. Chem.40,1–36 (2005).
  Medline CASGoogle Scholar
• 69  Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB: Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin. Rev. Allergy Immunol.23,301–324 (2002).
  Medline CASGoogle Scholar
• 70  Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA: Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc. Natl Acad. Sci. USA87,3279–3283 (1990).
  Medline CASGoogle Scholar
• 71  Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl Acad. Sci. USA93,705–708 (1996).
  Medline CASGoogle Scholar
• 72  Brown CS, Bertolet BD: Peripartum cardiomyopathy: a comprehensive review. Am. J. Obstet. Gynecol.178,409–414 (1998).
  Medline CASGoogle Scholar
• 73  McMullan MR, Moore CK, O’Connell JB: Diagnosis and management of peripartum cardiomyopathy. Hosp. Pract. (Off. Ed.)28,89–92, 96–98, 103–104 (1993).
  Medline CASGoogle Scholar
• 74  Jahns R, Boivin V, Hein L et al.: Direct evidence for a β 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest.113,1419–1429 (2004).
  Medline CASGoogle Scholar
• 75  Sundstrom JB, Fett JD, Carraway RD, Ansari AA: Is peripartum cardiomyopathy an organ-specific autoimmune disease? Autoimmun. Rev.1(1–2),73–77 (2002).
  MedlineGoogle Scholar
• 76  Warraich RS, Sliwa K, Damasceno A et al.: Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am. Heart J.150,263–269 (2005).
  Medline CASGoogle Scholar
• 77  Cenac A, Djibo A, Chaigneau C, Velmans N, Orfila J: Are anti-Chlamydia pneumoniae antibodies prognosis indicators for peripartum cardiomyopathy? J. Cardiovasc. Risk10,195–199 (2003).
  MedlineGoogle Scholar
• 78  Lamparter S, Pankuweit S, Maisch B: Clinical and immunologic characteristics in peripartum cardiomyopathy. Int. J. Cardiol.118,14–20 (2007).
  MedlineGoogle Scholar
• 79  Raskin RJ, Haddock JB, Lawless OJ: Systemic lupus erythematosus with myocarditis complicating pregnancy. South Med. J.76,258–260 (1983).
  Medline CASGoogle Scholar
• 80  Seo A, Sakamoto H, Tanaka Y et al.: Peripartum cardiomyopathy with antiphospholipid antibody: a case report. J. Cardiol.47,261–266 (2006).
  MedlineGoogle Scholar
• 81  Fett JD, Sundstrom BJ, Etta King M, Ansari AA: Mother–daughter peripartum cardiomyopathy. Int. J. Cardiol.86,331–332 (2002).
  MedlineGoogle Scholar
• 82  Fett JD: Peripartum cardiomyopathy. Insights from Haiti regarding a disease of unknown etiology. Minn. Med.85,46–48 (2002).
  MedlineGoogle Scholar
• 83  Fillmore SJ, Parry EH: The evolution of peripartal heart failure in Zaria, Nigeria. Some etiologic factors. Circulation56,1058–1061 (1977).
  Medline CASGoogle Scholar
• 84  Davies JE, Winokur TS, Aaron MF, Benza RL, Foley BA, Holman WL: Cardiomyopathy in a carrier of Duchenne’s muscular dystrophy. J. Heart Lung Transplant.20,781–784 (2001).
  Medline CASGoogle Scholar
• 85  Hoogerwaard EM, Ginjaar IB, Bakker E, de Visser M: Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Neurology65,1984–1986 (2005).
  Medline CASGoogle Scholar
• 86  Elsherif L, Huang MS, Shai SY et al.: Combined deficiency of dystrophin and β1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. Circ. Res.102,1109–1117 (2008).
  Medline CASGoogle Scholar
• 87  Hayakawa Y, Chandra M, Miao W et al.: Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gα_q transgenic mice. Circulation108,3036–3041 (2003).
  Medline CASGoogle Scholar
• 88  Diwan A, Wansapura J, Syed FM, Matkovich SJ, Lorenz JN, Dorn GW 2nd: Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation117,396–404 (2008).
  Medline CASGoogle Scholar
• 89  Shoji T, Yoshida S, Mitsunari M et al.: Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E₂ in human choriodecidua. J. Reprod. Immunol.75,82–90 (2007).
  Medline CASGoogle Scholar
• 90  Negoro S, Kunisada K, Fujio Y et al.: Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation104,979–981 (2001).
  Medline CASGoogle Scholar
• 91  Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature440,944–948 (2006).
  Medline CASGoogle Scholar
• 92  Corbacho AM, Martinez De La Escalera G, Clapp C: Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J. Endocrinol.173,219–238 (2002).
  Medline CASGoogle Scholar
• 93  Macotela Y, Aguilar MB, Guzman-Morales J et al.: Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin. J. Cell Sci.119,1790–1800 (2006).
  Medline CASGoogle Scholar
• 94  Tabruyn SP, Sorlet CM, Rentier-Delrue F et al.: The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-κB. Mol. Endocrinol.17,1815–1823 (2003).▪ More detailed information is discussed regarding the role of the 16 kDa cleavage form of prolactin.
  Medline CASGoogle Scholar
• 95  Gonzalez C, Corbacho AM, Eiserich JP et al.: 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology145,5714–5722 (2004).▪ Discussed several properties of 16 kDa prolactin.
  Medline CASGoogle Scholar
• 96  Tabruyn SP, Sabatel C, Nguyen NQ et al.: The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-κB activation. Mol. Endocrinol.21,1422–1429 (2007).
  Medline CASGoogle Scholar
• 97  Nagafuchi H, Suzuki N, Kaneko A, Asai T, Sakane T: Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol.26,1890–1900 (1999).
  Medline CASGoogle Scholar
• 98  Murali S, Baldisseri MR: Peripartum cardiomyopathy. Crit. Care Med.33,S340–S346 (2005).
  MedlineGoogle Scholar
• 99  James AH, Brancazio LR, Ortel TL: Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. Clin. Adv. Hematol. Oncol.3,187–197 (2005).
  MedlineGoogle Scholar
• 100  Box LC, Hanak V, Arciniegas JG: Dual coronary emboli in peripartum cardiomyopathy. Tex. Heart Inst. J.31,442–444 (2004).
  MedlineGoogle Scholar
• 101  Quinn B, Doyle B, McInerney J: Postnatal pre-cordial pain. Pulmonary embolism or peripartum cardiomyopathy. Emerg. Med. J.21,746–747 (2004).
  Medline CASGoogle Scholar
• 102  Bennani SL, Loubaris M, Lahlou I et al.: Postpartum cardiomyopathy revealed by acute lower limb ischemia. Ann. Cardiol. Angeiol. (Paris)52,382–385 (2003).
  Medline CASGoogle Scholar
• 103  Kaufman I, Bondy R, Benjamin A: Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient. Can. J. Anaesth.50,161–165 (2003).
  MedlineGoogle Scholar
• 104  Bozkurt B, Villaneuva FS, Holubkov R et al.: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J. Am. Coll. Cardiol.34,177–180 (1999).
  Medline CASGoogle Scholar
• 105  Turkalj I, Braun P, Krupp P: Surveillance of bromocriptine in pregnancy. JAMA247,1589–1591 (1982).
  Medline CASGoogle Scholar
• 106  Sliwa K, Forster O, Zhanje F, Candy G, Kachope J, Essop R: Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am. J. Cardiol.93,1441–1443, A10 (2004).
  MedlineGoogle Scholar
• 107  Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G: Peripartum cardiomyopathy – a new treatment option by inhibition of prolactin secretion. Am. J. Obstet. Gynecol.199,E5–E6 (2008).
  MedlineGoogle Scholar
• 108  Hopp L, Haider B, Iffy L: Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement. Int. J. Cardiol.57,227–232 (1996).
  Medline CASGoogle Scholar
• 109  Amos AM, Jaber WA, Russell SD: Improved outcomes in peripartum cardiomyopathy with contemporary. Am. Heart J.152,509–513 (2006).
  MedlineGoogle Scholar
• 110  Fett JD, Sannon H, Thelisma E, Sprunger T, Suresh V: Recovery from severe heart failure following peripartum cardiomyopathy. Int. J. Gynaecol. Obstet.104,125–127 (2009).
  MedlineGoogle Scholar